These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
771 related items for PubMed ID: 16855452
21. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease. Heo JH, Lee KM, Paek SH, Kim MJ, Lee JY, Kim JY, Cho SY, Lim YH, Kim MR, Jeong SY, Jeon BS. J Neurol Sci; 2008 Oct 15; 273(1-2):19-24. PubMed ID: 18640690 [Abstract] [Full Text] [Related]
23. The effect of escitalopram on sleep problems in depressed patients. Lader M, Andersen HF, Baekdal T. Hum Psychopharmacol; 2005 Jul 15; 20(5):349-54. PubMed ID: 15912558 [Abstract] [Full Text] [Related]
25. An open-label trial of escitalopram in the treatment of pathological gambling. Black DW, Shaw M, Forbush KT, Allen J. Clin Neuropharmacol; 2007 Jul 15; 30(4):206-12. PubMed ID: 17762317 [Abstract] [Full Text] [Related]
26. Pregnenolone for cognition and mood in dual diagnosis patients. Osuji IJ, Vera-Bolaños E, Carmody TJ, Brown ES. Psychiatry Res; 2010 Jul 30; 178(2):309-12. PubMed ID: 20493557 [Abstract] [Full Text] [Related]
30. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. MacLennan AH, Henderson VW, Paine BJ, Mathias J, Ramsay EN, Ryan P, Stocks NP, Taylor AW. Menopause; 2006 Jul 30; 13(1):28-36. PubMed ID: 16607096 [Abstract] [Full Text] [Related]
32. Treatment response and cognitive impairment in major depression: association with C-reactive protein. Chang HH, Lee IH, Gean PW, Lee SY, Chi MH, Yang YK, Lu RB, Chen PS. Brain Behav Immun; 2012 Jan 30; 26(1):90-5. PubMed ID: 21839826 [Abstract] [Full Text] [Related]
33. The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women. Pefanco MA, Kenny AM, Kaplan RF, Kuchel G, Walsh S, Kleppinger A, Prestwood K. J Am Geriatr Soc; 2007 Mar 30; 55(3):426-31. PubMed ID: 17341247 [Abstract] [Full Text] [Related]
34. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial. Bretlau LG, Lunde M, Lindberg L, Undén M, Dissing S, Bech P. Pharmacopsychiatry; 2008 Mar 30; 41(2):41-7. PubMed ID: 18311683 [Abstract] [Full Text] [Related]
36. Mood disorders after stroke: diagnostic validation of the poststroke depression rating scale. Quaranta D, Marra C, Gainotti G. Cerebrovasc Dis; 2008 Mar 30; 26(3):237-43. PubMed ID: 18648195 [Abstract] [Full Text] [Related]
37. The influence of educational information on depressed outpatients treated with escitalopram: a semi-naturalistic study. Leinonen E, Niemi H. Nord J Psychiatry; 2007 Mar 30; 61(2):109-14. PubMed ID: 17454725 [Abstract] [Full Text] [Related]
38. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia. Kim SW, Shin IS, Kim JM, Lee SH, Lee YH, Yang SJ, Yoon JS. Hum Psychopharmacol; 2009 Oct 30; 24(7):565-73. PubMed ID: 19790174 [Abstract] [Full Text] [Related]
39. Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression. Hsiao CC. Psychoneuroendocrinology; 2006 Aug 30; 31(7):839-46. PubMed ID: 16716529 [Abstract] [Full Text] [Related]
40. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder. Septien-Velez L, Pitrosky B, Padmanabhan SK, Germain JM, Tourian KA. Int Clin Psychopharmacol; 2007 Nov 30; 22(6):338-47. PubMed ID: 17917552 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]